Atsushi Aoyagi
0000-0002-8908-3855
Publication & Citation Trends
Publications
0 total
Structure-based design, synthesis, and evaluation of tetrahydrotriazolothiazepine derivatives as novel 11β-hydroxysteroid dehydrogenase type 1 inhibitors.
Cited by 0
Semantic Scholar
Correction to Supporting Information for Woerman et al., Familial Parkinson’s point mutation abolishes multiple system atrophy prion replication OA
Cited by 0
Semantic Scholar
CSF1R inhibitors induce a sex-specific resilient microglial phenotype and functional rescue in a tauopathy mouse model OA
Cited by 35
Semantic Scholar
Aβ and Tau Prions Causing Alzheimer's Disease.
Cited by 9
Semantic Scholar
Aβ and tau prions feature in the neuropathogenesis of Down syndrome OA
Cited by 18
Semantic Scholar
CSF1R inhibitor levels determine sex-specific phenotype of resilient microglia and neurofunctional rescue leading to extended survival in tauopathy mice OA
Cited by 3
Semantic Scholar
Sex-specific life extension in tauopathy mice by CSF1R inhibition causing selective microglial depletion and suppressed pathogenesis OA
Cited by 3
Semantic Scholar
Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 Activity. OA
Cited by 7
Semantic Scholar
Research Topics
Prion Diseases and Protein Misfolding
(11)
Alzheimer's disease research and treatments
(8)
Parkinson's Disease Mechanisms and Treatments
(5)
Neurological diseases and metabolism
(5)
Cholinesterase and Neurodegenerative Diseases
(4)
Affiliations
Howard Hughes Medical Institute
Daiichi Sankyo (Germany)
University of California, San Francisco
University of Washington
Daiichi Sankyo (United Kingdom)